Sfoglia per Autore
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare.
2005 Vaziri Farahani K; Gambetti S; Marinelli A; Leci E; Romanazzi S; Palazzini M; Negro L; Presotto L; Manes A; Galiè N; Branzi A.
Pulmonary arterial hypertension: therapeutic algorithm.
2005 Galie N; Branzi A.
Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD).
2005 Seibold JR; Langleben D; Badesch D; Naeije E; Simonneau G; Galie N; Barst RJ
Pulmonary hypertension: therapeutic algorithms.
2005 Galié N; Angelo Branzi
Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells
2005 B. Tantini; A. Manes; E. Fiumana; C. Pignatti; C. Guarnieri; R. Zannoli; A. Branzi; N. Galiè
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol.
2005 Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galie N; Humbert M; Rainisio M; Rubin LJ; Simonneau G.
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
2005 Oudiz RJ; Schilz RJ; Barst RJ; Galie N; Rich S; Rubin LJ; Simonneau G
Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
2005 Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst RJ
Pulmonary Arterial Hypertension associated to connective tissue diseases
2005 Galié N; Manes A; Vaziri Farahani K; Pelino F; Palazzini M; Negro L; Romanazzi S; Branzi A.
Effects of sildenafil on 1-year survival of patients with idiopathic pulmonary arterial hypertension (PAH
2005 Galie N;Burgess G;Parpia T; Rubin L.
Ambrisentan therapy for pulmonary arterial hypertension.
2005 Galie N; Badesch D; Oudiz R; Simonneau G; McGoon MD; Keogh AM; Frost AE;Zwicke D; Naeije R; Shapiro S; Olschewski H; Rubin LJ.
Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension: a comparison by etiology and baseline functional class
2005 Galie N; Frost A; Keogh A Zwicke; D Oudiz R; Naeije R; Olschewsky H; Rubin L.
Breathe-5: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology
2005 Galie N; Beghetti M; Gatzonlis N; Granton J; Berger R; Lauer A; Chiossi E; Landzberg M
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature.
2005 Bertoni M; Niccoli L; Porciello G; Storri L; Nannini C; Manes A; Palazzini M; Galie N; Cantini F.
Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension associated with connective tissue diseases.
2005 Badesch D; Zwicke D; Keogh AM; Galie N; Olschewski H; McGoon MD; McLaughlin V; Oudiz R; Frost AE; Simonneau G; Rubin LJ
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida.
2005 Manes A; Rocchi G; Ferlito M; Vaziri Farahani K; Romanazzi S; Negro L; Palazzini M; Presotto L; Marinelli A; Gambetti S; Leci E; Galie N; Branzi A
Predictive value of tricuspid regurgitation area in idiopathic pulmonary arterial hypertension patients treated according to current guidelines
2005 Manes A; Ferlito M; Pelino F; Rocchi G; Farahani KV; Bacchi-Reggiani L; Galie N; Branzi A
End points in pulmonary arterial hypertension: the way forward.
2005 Peacock A; Naeije R; Galie N; Reeves JT.
Sildenafil citrate therapy for pulmonary arterial hypertension
2005 Galiè, Nazzareno; Ghofrani, Hossein A.; Torbicki, Adam; Barst, Robyn J.; Rubin, Lewis J.; Badesch, David; Fleming, Thomas; Parpia, Tamiza; Burgess, Gary; Branzi, Angelo; Grimminger, Friedrich; Kurzyna, Marcin; Simonneau, Gérald
STRIDE-2 Trial: a placebo-controlled study for sitaxsentan in pulmonary arterial hypertension
2005 Galie N; Langleben D; Badesch D; Frost A; Lawrence EC; Naeije R Simonneau G; Barst R.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. | Vaziri Farahani K; Gambetti S; Marinelli A; Leci E; Romanazzi S; Palazzini M; Negro L; Presotto L...; Manes A; Galiè N; Branzi A. | 2005-01-01 | ITALIAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
| Pulmonary arterial hypertension: therapeutic algorithm. | Galie N; Branzi A. | 2005-01-01 | ITALIAN HEART JOURNAL | - | 1.01 Articolo in rivista | - |
| Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD). | Seibold JR; Langleben D; Badesch D; Naeije E; Simonneau G; Galie N; Barst RJ | 2005-01-01 | ARTHRITIS AND RHEUMATISM | - | 4.02 Riassunto (Abstract) | - |
| Pulmonary hypertension: therapeutic algorithms. | Galié N; Angelo Branzi | 2005-01-01 | ITALIAN HEART JOURNAL | - | 1.01 Articolo in rivista | - |
| Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells | B. Tantini; A. Manes; E. Fiumana; C. Pignatti; C. Guarnieri; R. Zannoli; A. Branzi; N. Galiè | 2005-01-01 | BASIC RESEARCH IN CARDIOLOGY | - | 1.01 Articolo in rivista | - |
| Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. | Sitbon O; McLaughlin VV; Badesch DB; Barst RJ; Black C; Galie N; Humbert M; Rainisio M; Rubin LJ;... Simonneau G. | 2005-01-01 | THORAX | - | 1.01 Articolo in rivista | - |
| Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. | Oudiz RJ; Schilz RJ; Barst RJ; Galie N; Rich S; Rubin LJ; Simonneau G | 2005-01-01 | CHEST | - | 1.01 Articolo in rivista | - |
| Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH). | Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst RJ | 2005-01-01 | ARTHRITIS AND RHEUMATISM | - | 4.02 Riassunto (Abstract) | - |
| Pulmonary Arterial Hypertension associated to connective tissue diseases | Galié N; Manes A; Vaziri Farahani K; Pelino F; Palazzini M; Negro L; Romanazzi S; Branzi A. | 2005-01-01 | LUPUS | - | 1.01 Articolo in rivista | - |
| Effects of sildenafil on 1-year survival of patients with idiopathic pulmonary arterial hypertension (PAH | Galie N;Burgess G;Parpia T; Rubin L. | 2005-01-01 | EUROPEAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
| Ambrisentan therapy for pulmonary arterial hypertension. | Galie N; Badesch D; Oudiz R; Simonneau G; McGoon MD; Keogh AM; Frost AE;Zwicke D; Naeije R; Shapi...ro S; Olschewski H; Rubin LJ. | 2005-01-01 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | - | 1.01 Articolo in rivista | - |
| Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension: a comparison by etiology and baseline functional class | Galie N; Frost A; Keogh A Zwicke; D Oudiz R; Naeije R; Olschewsky H; Rubin L. | 2005-01-01 | EUROPEAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
| Breathe-5: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology | Galie N; Beghetti M; Gatzonlis N; Granton J; Berger R; Lauer A; Chiossi E; Landzberg M | 2005-01-01 | CHEST | - | 4.02 Riassunto (Abstract) | - |
| Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. | Bertoni M; Niccoli L; Porciello G; Storri L; Nannini C; Manes A; Palazzini M; Galie N; Cantini F. | 2005-01-01 | CLINICAL RHEUMATOLOGY | - | 1.01 Articolo in rivista | - |
| Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension associated with connective tissue diseases. | Badesch D; Zwicke D; Keogh AM; Galie N; Olschewski H; McGoon MD; McLaughlin V; Oudiz R; Frost AE;... Simonneau G; Rubin LJ | 2005-01-01 | ARTHRITIS AND RHEUMATISM | - | 4.02 Riassunto (Abstract) | - |
| Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. | Manes A; Rocchi G; Ferlito M; Vaziri Farahani K; Romanazzi S; Negro L; Palazzini M; Presotto L; M...arinelli A; Gambetti S; Leci E; Galie N; Branzi A | 2005-01-01 | ITALIAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
| Predictive value of tricuspid regurgitation area in idiopathic pulmonary arterial hypertension patients treated according to current guidelines | Manes A; Ferlito M; Pelino F; Rocchi G; Farahani KV; Bacchi-Reggiani L; Galie N; Branzi A | 2005-01-01 | EUROPEAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
| End points in pulmonary arterial hypertension: the way forward. | Peacock A; Naeije R; Galie N; Reeves JT. | 2005-01-01 | EUROPEAN RESPIRATORY JOURNAL | - | 1.01 Articolo in rivista | - |
| Sildenafil citrate therapy for pulmonary arterial hypertension | Galiè, Nazzareno; Ghofrani, Hossein A.; Torbicki, Adam; Barst, Robyn J.; Rubin, Lewis J.; Badesch..., David; Fleming, Thomas; Parpia, Tamiza; Burgess, Gary; Branzi, Angelo; Grimminger, Friedrich; Kurzyna, Marcin; Simonneau, Gérald | 2005-01-01 | NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
| STRIDE-2 Trial: a placebo-controlled study for sitaxsentan in pulmonary arterial hypertension |
Galie N; Langleben D; Badesch D; Frost A; Lawrence EC; Naeije R Simonneau G; Barst R. |
2005-01-01 | EUROPEAN HEART JOURNAL | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile